MIT Sloan BioInnovations 2007

2004
2005
2006
2007
2008
2009
2010

MIT Sloan BioInnovations Conference Friday, April 13th, 2007

MIT Sloan School of Management
Kendall Square, Cambridge MA

Senior industry management, investors, and academics from the Massachusetts biotechnology community convene for a day of substantive idea exchange.

The Agenda

8:00	Registration and Morning Networking
9:00	Introduction of Morning Keynote
	Morning Keynote Speaker John Maraganore, Ph.D. President & CEO, Alnylam Pharmaceuticals
10:00	Networking
10:30	Morning Panels The Risks and Rewards of Technology Transfer–Discussing the trials and tribulations surrounding intellectual property and licensing strategies Panel Moderator Ingrid Beattie, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C. Panel Participants Charles Cooney , Faculty Director, MIT Desphande Center Lita Nelsen , Director, MIT Technology Licensing Office Laura Paglione, Director of iBridge Network, Kauffman Foundation John White, Cooper & Dunham LLP Gary Frashier, President and Principal, Management Associates Trends in Corporate Entrepreneurship–Investigating how life sciences corporations maintain an entrepreneurial spirit to sustain a growing business Panel Moderator Chris Brabham, Partner, PricewaterhouseCoopers LLP Panel Participants Rainer Fuchs, Ph.D., VP & Executive Director, Biogen Idec Innovation Incubator Stephen Potter, SVP Corporate Development, Genzyme Steven Weinstein, Managing Director, Novartis Venture Fund David Freeman, Chief Marketing Officer, GE Healthcare Monitoring Solutions
11:40	Special Guest Lecturer Fred Middleton Managing Director, Sanderling Ventures
12:30	Introduction of Robert A. Swanson Memorial Lecturer Judy Swanson Robert A. Swanson Memorial Entrepreneurship Lectures were created to acknowledge and perpetuate Bob Swanson's special qualities of leadership, passion, and entrepreneurship. Bob was the founder of Genentech, the sparkplug of the Big Bang of the Biotech Industry. He held an S.B. degree in Chemistry from MIT as well as an M.B.A. from the MIT Sloan School of Management. Robert A. Swanson Memorial Lecturer Deborah Dunsire, M.D. President & CEO, Millennium Pharmaceuticals Lunch at the Boston Marriott Cambridge (Kendall Square)
2:30	Afternoon Panels The Next Big Thing in Life Sciences–Exploring the new therapies that will shape the way patients are treated and the entrepreneurs pursuing these therapies Panel Moderator Steve Wardell , Executive Vice President of Finance and Corporate Development, NorthPoint Domain, Inc. Panel Participants Mara Aspinall, President, Genzyme Genetics Stanley Lapidus, President & CEO, Helicos BioSciences Kevin Eggan, Assistant Professor of Molecular and Cellular Biology, Harvard University Michelle Dipp, MD, PhD, Director of Corporate Development, Sirtris Pharmaceuticals Entrepreneurship Strategies in International Environments–Understanding the strategic aspects of pursuing entrepreneurship outside of the US Panel Moderator Brenda Herschbach Jarrell, Ph.D., Partner, Choate Hall & Stewart LLP Panel Participants Robert Forrester, CFO, CombinatoRx Rich Kivel, CEO, Theragenetics Anupendra Sharma, Partner, Siemens Healthcare Solutions Fund Pravin R. Chaturvedi, Ph.D., Chairman & CEO, IndUS Pharmaceuticals
3:30	Networking
4:00	Closing Panel Trends in Exit Strategies –Assessing the dynamics of the life sciences start-up environment with insights from leading venture capitalists and financiers Panel Moderator Steve Dickman, CEO, CBT Advisors Panel Participants Bruce Booth, Principal, Atlas Venture David Cassak, Managing Partner, Windhover Information Inc. Stuart Duty, Managing Director, Piper Jaffray Jean George, General Partner, Advanced Technology Ventures